Whistleblower Qui Tam Case Involving Medication Therapy Management Services and Manufacturer Drug Coupons Settles Against Pharmacy for $2.9 Million 

Rabin Kammerer Johnson (“RKJ”) and Searcy Denney Scarola Barnhart & Shipley (“Searcy Denney”) announce that they have settled a whistleblower qui tam case brought against a pharmacy for $2.9 million. The case involved allegations that the pharmacy was performing medication therapy management services and accepting drug manufacturer coupons to cover or discount copayments in violation of federal Medicare statutes and regulations.  

The whistleblowers will share in the settlement proceeds paid to the Government to reimburse the federal Medicare program. The case was handled by RKJ attorneys Adam Rabin, Havan Clark, and Andrew Abreu and Searcy Denney attorney Sia Baker-Barnes. 

The federal False Claims Act allows whistleblowers to share in the recovery of funds that the Government pays out for false or fraudulent claims.  If you know of a company or person that has committed fraud against the Government for Medicare fraud, contact us at 561-659-7878.